Goodwin advised Scholar Rock Holding Corporation on the offering. Scholar Rock Holding Corporation (Nasdaq: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now